Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: CMC PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-02-14 to 2022-08-14
Current total value of award: $167076.48
Description: PHASE I RESEARCH & DEVELOPMENT - FORMULATION AND ANALYTICAL DEVELOPMENT OF A MULTI-DOSE VIAL PRESENTATION OF SCOPOLAMINE HYDROBROMIDE TRIHYDRATE CONTAINING A ANTIMICROBIAL PRESERVATIVES (AMP).